References
- Shenolikar S. Protein phosphorylation: hormones, drugs, and bioregulation. FASEB J. 1988; 2: 2753–2764
- Rasmussen H., Takuwa Y., Park S. Protein kinase C in the regulation of smooth muscle contraction. FASEB J. 1987; 1: 177–185
- Khalil R. A., van Breeman C. Sustained contraction of vascular smooth muscle: calcium intake or C-kinase activation?. J. Pharmacol Exp Ther. 1988; 244: 537–542
- Omura S., Iwai Y., Hirano A., Nakagawa A., Awaya J., Tsuchiya H., Takahashi Y., Masuma R. A new alkaloid AM-2282 of Streptomyces origin taxonomy fermentation isolation and preliminary characterization. J Antibiotics 1977; 30: 275–281
- Tamaoki T., Nomoto H., Takahashi I., Kato Y., Morimoto M., Tomita F. Staurosporine, a potent inhibitor of phospholipid/Ca++ dependent protein kinase. Biochem Biophys Res Comm. 1986; 135: 397–402
- Nakadate T., Jeng A. Y., Blumberg P. M. Comparison of protein kinase C functional assays to clarify mechanisms of inhibitor action. Biochem Pharmacol. 1988; 37: 1541–1545
- Watson S. P., McNally J., Shipman L. J., Godfrey P. P. The action of the protein kinase C inhibitor, staurosporine, on human platelets. Biochem J. 1988; 249: 345–350
- Nakano H., Kobayashi E., Takahashi I., Tamaoki T., Kuzuu Y., Iba H. Staurosporine inhibits tyrosine-specific protein kinase activity of Rous sarcoma virus transforming protein p60. J Antibiotics 1987; 40: 706–708
- Steel R. G. D., Torrie J. H. Principles and Procedures of Statistics. McGraw-Hill, New York, N. Y. 1960; 347–349
- Randolph L. K., Ciminera, Statistics J. L. Remington's Pharmaceutical Sciences. Mack Publishing Co., Easton, PA 1985; 104–140
- Morioka H., Ishihara M., Shibai G., Suzuki T. Staurosporine-induced differentiation in a human neuro-blastoma cell line, NB-1. Agric Biol Chem. 1985; 49: 1959–1963
- Schachtele C., Seifert R., Osswald H. Stimulus-dependent inhibition of platelet aggregation by the protein kinase C inhibitors polymyxin B, H-7, and staurosporine. Biochem Biophys Res Comm. 1988; 151: 542–547
- Hachisu M., Hiranuma T., Koyama M., Sezaki M. Antihypertensive compounds with potent protein kinase inhibitory activity. Life Sci. 1989; 44: 1351–1362
- Rasmussen H., Forder J., Kojima I., Scriabine A. TPR-induced contraction of isolated rabbit vascular smooth muscle. Biochem Biophys Res Commun. 1984; 122: 776–784
- Ruskoako H. Effect of atenolol and pindolol on the phorbol ester-induced coronary vasoconstriction in the isolated perfused heart of the rat. Br J Pharmacol. 1988; 94: 573–583
- Forder J., Scriabine A., Rasmussen H. Plasma membrane calcium flux, protein kinase C activation and smooth muscle contraction. J Pharmacol Exp Ther. 1985; 235: 267–273
- Deragon G., Regoli D., Rioux F. The effects of vasodilators in the perfused hind limbs of spontaneously hypertensive and normotensive rats. Can J Physiol Pharmacol. 1978; 56(624)629
- Spector S., Fleisch J. H., Maling H. M., Brodie B. B. Vascular smooth muscle reactivity in normotensive and hypertensive rats. Science 1969; 166: 1300–1301